See every side of every news story
Published loading...Updated

AstraZeneca scraps £450m vaccine plant in Liverpool after Labour funding cut

  • AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool due to a cut in funding from the government, as stated by the pharmaceutical giant.
  • The investment was initially announced as a 'vote of confidence' in Liverpool and the UK's life science sector, but Labour ministers offered less funding than before.
  • An AstraZeneca spokesperson noted that 'Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous government's proposal.'
  • The government stated that a 'change in the make-up of the investment' led to a reduced grant offer, highlighting the need for taxpayer value.
Insights by Ground AI
Does this summary seem wrong?

40 Articles

All
Left
5
Center
6
Right
7
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 39% of the sources lean Right
39% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Telegraph broke the news in London, United Kingdom on Friday, January 31, 2025.
Sources are mostly out of (0)